Serum CXCL10 as a potential biomarker for lupus nephritis and disease activity: evidence from an Egyptian cohort. [PDF]
Badr FM +3 more
europepmc +1 more source
Regulatory B cell expansion and type 1 innate lymphoid cell suppression characterise immune modulation in paediatric lupus nephritis. [PDF]
Lin CY +10 more
europepmc +1 more source
Case report and literature review: neuropsychiatric systemic lupus erythematosus presenting as massive intracerebral hemorrhage. [PDF]
Fang Y +6 more
europepmc +1 more source
Correction: MiR-1290 in natural killer cell derived extracellular vesicles: a pathogenic mediator of lupus nephritis and therapeutic target for th17 regulation. [PDF]
Cheng C +7 more
europepmc +1 more source
Acute Kidney Injury, Fever, and Dark Urine in a Kidney Transplant Recipient. [PDF]
Rosenstiel PE, Goyal A.
europepmc +1 more source
Safety and Efficacy of Obinutuzumab in Treating Lupus Nephritis: A Systematic Review. [PDF]
Arif Z +4 more
europepmc +1 more source
Beyond renal response: sustained systemic disease control protects against adverse long-term outcomes in lupus nephritis. [PDF]
Drougkas K +15 more
europepmc +1 more source
Anesthetic Considerations in ESRD Secondary to Lupus Nephritis. [PDF]
Ghotra K, Grabowski C, Weber M.
europepmc +1 more source
Posterior Reversible Encephalopathy Syndrome (PRES) as the Initial Presentation of Systemic Lupus Erythematosus With Lupus Nephritis: A Case Report. [PDF]
De Clercq C +3 more
europepmc +1 more source

